Amplification of oncogenes revisited: from expression profiling to clinical application.
about
Functional interaction of Yaf2 with the central region of MycNArchitectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolutionChromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinomaCombined subtractive cDNA cloning and array CGH: an efficient approach for identification of overexpressed genes in DNA ampliconsCarcinogenesis: The more we seek to know the more we need to know - Challenges in the post Genomic EraAmplification of Cellular Oncogenes in Solid TumorsOn the mechanism of gene amplification induced under stress in Escherichia coli2p24 Gain region harboring MYCN gene compared with MYCN amplified and nonamplified neuroblastoma: biological and clinical characteristics.Genomic instability in breast cancer: pathogenesis and clinical implicationsHigh-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells.Overexpression of the amplified Pip4k2beta gene from 17q11-12 in breast cancer cells confers proliferation advantage.Fusion of the Dhfr/Mtx and IR/MAR gene amplification methods produces a rapid and efficient method for stable recombinant protein production.MYCN enhances P-gp/MDR1 gene expression in the human metastatic neuroblastoma IGR-N-91 model.Mutation as a stress response and the regulation of evolvabilityEvidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification.Generalized principles of stochasticity can be used to control dynamic heterogeneityTranscriptional Repression of IFN Regulatory Factor 7 by MYC Is Critical for Type I IFN Production in Human Plasmacytoid Dendritic CellsCoamplification of multiple regions of chromosome 2, including MYCN, in a single patchwork amplicon in cancer cell lines.The FRA2C common fragile site maps to the borders of MYCN amplicons in neuroblastoma and is associated with gross chromosomal rearrangements in different cancers.19q13 amplification is associated with high grade and stage in pancreatic cancer.Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines.E2F and Sp1/Sp3 Synergize but are not sufficient to activate the MYCN gene in neuroblastomas.A subset of breast invasive ductal carcinoma with distinctive cytomorphology, aggressive clinical behavior, and unique immunologic profiles.E2F proteins regulate MYCN expression in neuroblastomas.Stress-induced cellular adaptive strategies: ancient evolutionarily conserved programs as new anticancer therapeutic targets.Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11qMYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target geneImmune and genomic signatures in oral (head and neck) cancer
P2860
Q24291776-0B144C43-A44D-4BFC-B55B-1C4A456A5157Q24676904-0DB1FC61-9532-4206-B8F7-4B99386E8243Q24799110-20B90665-06F6-4BFD-9DF4-839FB762C6AAQ24799947-D5CE9FEC-31EE-4219-8395-4B426C9CBCD7Q24801574-CA3AFE80-C084-406F-8CCC-C82F28866348Q26784582-E46F80B2-E106-4CC0-B889-80EBDFBC96A0Q33239373-F99F35B5-FF57-4CC5-BA7B-9E32E2385E19Q33882364-316A0803-C0AE-47FE-AFAA-2D414223E491Q33998514-0CBF9F3E-EBA8-4809-9259-8BF159632F12Q34038356-0DEB246B-28B7-4C62-90DC-C0CEE7044FC7Q34285811-AF6A77E7-B4E6-4788-A9C4-A0150E3CDC8EQ34541494-C64765EA-291B-4086-B16B-EE5387A5DF9FQ35791530-C60B6BDE-1A75-488B-B182-F8D886D80BDBQ35869358-013B23C7-52CF-4F37-BD4B-05E843ABA899Q36376595-03AB52C7-DF58-4F5D-869A-E1AAFC9999B1Q36745875-5B27CEC0-3D03-4CD8-8C52-9CC329D80422Q38746231-32408E8C-1A30-4FEB-966E-CCF193E71765Q39436257-FE5A6EBD-6EE0-4020-BD76-DD7EEABD7F03Q39604153-6798ECB3-DECA-4974-89A0-6C7413730C60Q40045624-83ACCEBA-2CBD-4CF1-87B7-EB5A8A43BC5AQ40291449-B6E157B2-CF8D-4ADC-BA20-85FBB4909B0AQ40612870-FB2F11FA-2C4C-4F1B-A0CD-D0BD866F607EQ44178439-7EA7AA24-07EA-4FF9-874D-B2B22A8D92D0Q44220811-E0278A65-2752-4630-92F0-B4B00F26E75AQ47655848-9B0534D7-BA7B-4E6B-9FE0-B374430220D8Q57270554-5C31D3C3-5A77-4C76-9DF7-D8EAF048106DQ57690359-3871F025-433F-47B7-8C2F-8AF50FBF3389Q58700648-25835BF0-7E70-4932-A0B7-377857E0EEFA
P2860
Amplification of oncogenes revisited: from expression profiling to clinical application.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Amplification of oncogenes revisited: from expression profiling to clinical application.
@ast
Amplification of oncogenes revisited: from expression profiling to clinical application.
@en
Amplification of oncogenes revisited: from expression profiling to clinical application.
@nl
type
label
Amplification of oncogenes revisited: from expression profiling to clinical application.
@ast
Amplification of oncogenes revisited: from expression profiling to clinical application.
@en
Amplification of oncogenes revisited: from expression profiling to clinical application.
@nl
prefLabel
Amplification of oncogenes revisited: from expression profiling to clinical application.
@ast
Amplification of oncogenes revisited: from expression profiling to clinical application.
@en
Amplification of oncogenes revisited: from expression profiling to clinical application.
@nl
P1433
P1476
Amplification of oncogenes revisited: from expression profiling to clinical application.
@en
P2093
P304
P356
10.1016/S0304-3835(01)00472-4
P407
P577
2001-06-01T00:00:00Z